Homeostasis imbalance in the endometrium of women with implantation defects: The role of estrogen and progesterone

Seminars in Reproductive Medicine

Volumn 32, Issue 5, 2014, Pages 365-375

  Lessey, Bruce A ^a   Young, Steven L ^b  

^a GREENVILLE HOSPITAL SYSTEM   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

endometriosis; endometrium; infertility; menstrual cycle; progesterone and estrogen

Indexed keywords

ESTROGEN; PROGESTERONE;

ARTICLE; ENDOMETRIOSIS; ENDOMETRIUM; ESTROGEN ACTIVITY; FEMALE INFERTILITY; HOMEOSTASIS; MENSTRUATION; NIDATION; OVULATION; FEMALE; HUMAN; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY;

EMBRYO IMPLANTATION; ENDOMETRIOSIS; ENDOMETRIUM; ESTROGENS; FEMALE; HOMEOSTASIS; HUMANS; INFERTILITY, FEMALE; PROGESTERONE;

EID: 84903167950     PISSN: 15268004     EISSN: 15264564     Source Type: Journal    
DOI: 10.1055/s-0034-1376355     Document Type: Article

References (191)

1. Coussens L. M., Werb Z. Inflammation and cancer. Nature: 2002; 420 6917 860 867 (Pubitemid 36019639)
2. Grimble R. F. Inflammatory status and insulin resistance. Curr Opin Clin Nutr Metab Care: 2002; 5 5 551 559 (Pubitemid 40684652)
3. Figarella-Branger D., Civatte M., Bartoli C., Pellissier J. F. Cytokines, chemokines, and cell adhesion molecules in inflammatory myopathies. Muscle Nerve: 2003; 28 6 659 682 (Pubitemid 37484828)
4. Benelli R., Lorusso G., Albini A., Noonan D. M. Cytokines and chemokines as regulators of angiogenesis in health and disease. Curr Pharm Des: 2006; 12 24 3101 3115 (Pubitemid 44227572)
5. Charo I. F., Ransohoff R. M. The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med: 2006; 354 6 610 621 (Pubitemid 43209108)
6. Martin G. R., Wallace J. L. Gastrointestinal inflammation: a central component of mucosal defense and repair. Exp Biol Med (Maywood): 2006; 231 2 130 137 (Pubitemid 43213449)
7. Kulinsky V. I. Biochemical aspects of inflammation. Biochemistry (Mosc): 2007; 72 6 595 607 (Pubitemid 47142359)
8. Carlo T., Levy B. D. Molecular circuits of resolution in airway inflammation. ScientificWorldJournal: 2010; 10 1386 1399
9. Mathis D., Shoelson S. E. Immunometabolism: an emerging frontier. Nat Rev Immunol: 2011; 11 2 81
10. Shachar I., Karin N. The dual roles of inflammatory cytokines and chemokines in the regulation of autoimmune diseases and their clinical implications. J Leukoc Biol: 2013; 93 1 51 61
11. Serhan C. N. Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways. Annu Rev Immunol: 2007; 25 101 137 (Pubitemid 46697904)
12. Serhan C. N., Chiang N., Van Dyke T. E. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol: 2008; 8 5 349 361 (Pubitemid 351595216)
13. Lessey B. A., Lebovic D. I., Taylor R. N. Eutopic endometrium in women with endometriosis: ground zero for the study of implantation defects. Semin Reprod Med: 2013; 31 2 109 124
14. Genbacev O. D., Prakobphol A., Foulk R. A., et al. Trophoblast L-selectin-mediated adhesion at the maternal-fetal interface. Science: 2003; 299 5605 405 408 (Pubitemid 36120046)
15. Dominguez F., Yáñez-Mó M., Sanchez-Madrid F., Simón C. Embryonic implantation and leukocyte transendothelial migration: different processes with similar players? FASEB J: 2005; 19 9 1056 1060 (Pubitemid 40946430)
16. Lea R. G., Sandra O. Immunoendocrine aspects of endometrial function and implantation. Reproduction: 2007; 134 3 389 404 (Pubitemid 47386887)
17. Macdonald L. J., Boddy S. C., Denison F. C., Sales K. J., Jabbour H. N. A role for lipoxin A, as an anti-inflammatory mediator in the human endometrium. Reproduction: 2011; 142 2 345 352
18. Winger E. E., Reed J. L., Ashoush S., El-Toukhy T., Ahuja S., Taranissi M. Degree of TNF-α/IL-10 cytokine elevation correlates with IVF success rates in women undergoing treatment with Adalimumab (Humira) and IVIG. Am J Reprod Immunol: 2011; 65 6 610 618
19. Granot I., Gnainsky Y., Dekel N. Endometrial inflammation and effect on implantation improvement and pregnancy outcome. Reproduction: 2012; 144 6 661 668
20. Barash A., Dekel N., Fieldust S., Segal I., Schechtman E., Granot I. Local injury to the endometrium doubles the incidence of successful pregnancies in patients undergoing in vitro fertilization. Fertil Steril: 2003; 79 6 1317 1322 (Pubitemid 36687877)
21. Agic A., Xu H., Finas D., Banz C., Diedrich K., Hornung D. Is endometriosis associated with systemic subclinical inflammation? Gynecol Obstet Invest: 2006; 62 3 139 147 (Pubitemid 44474973)
22. Wu M. H., Lu C. W., Chuang P. C., Tsai S. J. Prostaglandin E2: the master of endometriosis? Exp Biol Med (Maywood): 2010; 235 6 668 677
23. Canny G. O., Lessey B. A. The role of lipoxin A4 in endometrial biology and endometriosis. Mucosal Immunol: 2013; 6 3 439 450
24. Berbic M., Fraser I. S. Regulatory T cells and other leukocytes in the pathogenesis of endometriosis. J Reprod Immunol: 2011; 88 2 149 155
25. Bulmer J. N., Jones R. K., Searle R. F. Intraepithelial leukocytes in endometriosis and adenomyosis: comparison of eutopic and ectopic endometrium with normal endometrium. Hum Reprod: 1998; 13 2910 2915 (Pubitemid 28482750)
26. Jones R. K., Bulmer J. N., Searle R. F. Immunohistochemical characterization of stromal leukocytes in ovarian endometriosis: comparison of eutopic and ectopic endometrium with normal endometrium. Fertil Steril: 1996; 66 1 81 89 (Pubitemid 26190025)
27. Lessey B. A., Killam A. P., Metzger D. A., Haney A. F., Greene G. L., McCarty K. S. Jr. Immunohistochemical analysis of human uterine estrogen and progesterone receptors throughout the menstrual cycle. J Clin Endocrinol Metab: 1988; 67 2 334 340
28. Brenner R. M., McClellan M. C., West N. B., Novy M. J., Haluska G. J., Sternfeld M. D. Estrogen and progestin receptors in the macaque endometrium. Ann N Y Acad Sci: 1991; 622 149 166
29. Critchley H. O., Brenner R. M., Henderson T. A., et al. Estrogen receptor beta, but not estrogen receptor alpha, is present in the vascular endothelium of the human and nonhuman primate endometrium. J Clin Endocrinol Metab: 2001; 86 3 1370 1378 (Pubitemid 32323030)
30. Garcia E., Bouchard P., De Brux J., et al. Use of immunocytochemistry of progesterone and estrogen receptors for endometrial dating. J Clin Endocrinol Metab: 1988; 67 1 80 87
31. Padykula H. A., Coles L. G., Okulicz W. C., et al. The basalis of the primate endometrium: a bifunctional germinal compartment. Biol Reprod: 1989; 40 3 681 690 (Pubitemid 19149774)
32. Okulicz W. C., Ace C. I., Scarrell R. Zonal changes in proliferation in the rhesus endometrium during the late secretory phase and menses. Proc Soc Exp Biol Med: 1997; 214 2 132 138
33. Brenner R. M., West N. B., McClellan M. C. Estrogen and progestin receptors in the reproductive tract of male and female primates. Biol Reprod: 1990; 42 1 11 19 (Pubitemid 20097075)
34. Tan J., Paria B. C., Dey S. K., Das S. K. Differential uterine expression of estrogen and progesterone receptors correlates with uterine preparation for implantation and decidualization in the mouse. Endocrinology: 1999; 140 11 5310 5321
35. de Ziegler D. Hormonal control of endometrial receptivity. Hum Reprod: 1995; 10 1 4 7
36. de Ziegler D., Bergeron C., Cornel C., et al. Effects of luteal estradiol on the secretory transformation of human endometrium and plasma gonadotropins. J Clin Endocrinol Metab: 1992; 74 2 322 331
37. de Ziegler D., Frydman R., Bouchard P. Contribution of estrogen to the morphology of secretory endometrium? Fertil Steril: 1995; 63 5 1135
38. Lee D. K., Kurihara I., Jeong J. W., et al. Suppression of ERalpha activity by COUP-TFII is essential for successful implantation and decidualization. Mol Endocrinol: 2010; 24 5 930 940
39. Lessey B. A., Palomino W. A., Apparao K. B., Young S. L., Lininger R. A. Estrogen receptor-alpha (ER-alpha) and defects in uterine receptivity in women. Reprod Biol Endocrinol: 2006; 4 01 S9
40. Park J. S., Lee J. H., Kim M., Chang H. J., Hwang K. J., Chang K. H. Endometrium from women with endometriosis shows increased proliferation activity. Fertil Steril: 2009; 92 4 1246 1249
41. Young S. L., Lessey B. A. Progesterone function in human endometrium: clinical perspectives. Semin Reprod Med: 2010; 28 1 5 16
42. Noble L. S., Simpson E. R., Johns A., Bulun S. E. Aromatase expression in endometriosis. J Clin Endocrinol Metab: 1996; 81 1 174 179 (Pubitemid 26035021)
43. Li X., Large M. J., Creighton C. J., et al. COUP-TFII regulates human endometrial stromal genes involved in inflammation. Mol Endocrinol: 2013; 27 12 2041 2054
44. Talbi S., Hamilton A. E., Vo K. C., et al. Molecular phenotyping of human endometrium distinguishes menstrual cycle phases and underlying biological processes in normo-ovulatory women. Endocrinology: 2006; 147 3 1097 1121 (Pubitemid 43244341)
45. Cooke P. S., Buchanan D. L., Young P., et al. Stromal estrogen receptors mediate mitogenic effects of estradiol on uterine epithelium. Proc Natl Acad Sci U S A: 1997; 94 12 6535 6540 (Pubitemid 27270720)
46. Dickson R. B., Lippman M. E. Estrogenic regulation of growth and polypeptide growth factor secretion in human breast carcinoma. Endocr Rev: 1987; 8 1 29 43
47. Ritvos O., Ranta T., Jalkanen J., et al. Insulin-like growth factor (IGF) binding protein from human decidua inhibits the binding and biological action of IGF-I in cultured choriocarcinoma cells. Endocrinology: 1988; 122 5 2150 2157
48. Prossnitz E. R., Arterburn J. B., Sklar L. A. GPR30: A G protein-coupled receptor for estrogen. Mol Cell Endocrinol: 2007; 265-266 138 142 (Pubitemid 46273957)
49. Smith H. O., Arias-Pulido H., Kuo D. Y., et al. GPR30 predicts poor survival for ovarian cancer. Gynecol Oncol: 2009; 114 3 465 471
50. Prossnitz E. R., Maggiolini M. Mechanisms of estrogen signaling and gene expression via GPR30. Mol Cell Endocrinol: 2009; 308 1-2 32 38
51. Li Q., Kannan A., DeMayo F. J., et al. The antiproliferative action of progesterone in uterine epithelium is mediated by Hand2. Science: 2011; 331 6019 912 916
52. Kurihara I., Lee D. K., Petit F. G., et al. COUP-TFII mediates progesterone regulation of uterine implantation by controlling ER activity. PLoS Genet: 2007; 3 6 e102
53. Lee D. K., Kurihara I., DeMayo F., Tsai M. J., Tsai S. Y. ICI 182,780, a pure ERa antagonist partially rescued the implantation and decidualization defects in uterine specific COUP-TFII deficient mice. SCCPRIR Research Meeting; 2009; Chicago, IL
54. Xiong J., Zeng P., Cheng X., et al. Lipoxin A4 blocks embryo implantation by controlling estrogen receptor a activity. Reproduction 2013; Advance Publication (REP-12-0469)
55. Miller P. B., Parnell B. A., Bushnell G., et al. Endometrial receptivity defects during IVF cycles with and without letrozole. Hum Reprod: 2012; 27 3 881 888
56. Straub R. H. The complex role of estrogens in inflammation. Endocr Rev: 2007; 28 5 521 574 (Pubitemid 47236336)
57. Cutolo M., Capellino S., Sulli A., et al. Estrogens and autoimmune diseases. Ann N Y Acad Sci: 2006; 1089 538 547 (Pubitemid 47092097)
58. Sakiani S., Olsen N. J., Kovacs W. J. Gonadal steroids and humoral immunity. Nat Rev Endocrinol: 2013; 9 1 56 62
59. Olsen N. J., Kovacs W. J. Gonadal steroids and immunity. Endocr Rev: 1996; 17 4 369 384 (Pubitemid 26277980)
60. Zhang X., Xu H., Lin J., Qian Y., Deng L. Peritoneal fluid concentrations of interleukin-17 correlate with the severity of endometriosis and infertility of this disorder. BJOG: 2005; 112 8 1153 1155 (Pubitemid 41632675)
61. Andreoli C. G., Genro V. K., Souza C. A., et al. T helper (Th)1, Th2, and Th17 interleukin pathways in infertile patients with minimal/mild endometriosis. Fertil Steril: 2011; 95 8 2477 2480
62. Hirata T., Osuga Y., Takamura M., et al. Interleukin-17F increases the secretion of interleukin-8 and the expression of cyclooxygenase 2 in endometriosis. Fertil Steril: 2011; 96 1 113 117
63. Boomsma C. M., Kavelaars A., Eijkemans M. J., et al. Cytokine profiling in endometrial secretions: a non-invasive window on endometrial receptivity. Reprod Biomed Online: 2009; 18 1 85 94
64. Fujimoto J., Hori M., Ichigo S., Tamaya T. Ovarian steroids regulate the expression of basic fibroblast growth factor and its mRNA in fibroblasts derived from uterine endometrium. Ann Clin Biochem: 1997; 34 Pt 1 91 96 (Pubitemid 27067875)
65. Presta M. Sex hormones modulate the synthesis of basic fibroblast growth factor in human endometrial adenocarcinoma cells: implications for the neovascularization of normal and neoplastic endometrium. J Cell Physiol: 1988; 137 3 593 597 (Pubitemid 19006749)
66. Gagliardi A. R., Hennig B., Collins D. C. Antiestrogens inhibit endothelial cell growth stimulated by angiogenic growth factors. Anticancer Res: 1996; 16 1101 1106 (Pubitemid 26229771)
67. Irwin J. C., Utian W. H., Eckert R. L. Sex steroids and growth factors differentially regulate the growth and differentiation of cultured human endometrial stromal cells. Endocrinology: 1991; 129 5 2385 2392
68. Kanda N., Watanabe S. 17beta-estradiol inhibits the production of RANTES in human keratinocytes. J Invest Dermatol: 2003; 120 3 420 427 (Pubitemid 36298428)
69. Kanda N., Watanabe S. 17Beta-estradiol inhibits MCP-1 production in human keratinocytes. J Invest Dermatol: 2003; 120 6 1058 1066 (Pubitemid 36702918)
70. Akoum A., Jolicoeur C., Boucher A. Estradiol amplifies interleukin-1-induced monocyte chemotactic protein-1 expression by ectopic endometrial cells of women with endometriosis. J Clin Endocrinol Metab: 2000; 85 2 896 904 (Pubitemid 32273685)
71. Akoum A., Lawson C., McColl S., Villeneuve M. Ectopic endometrial cells express high concentrations of interleukin (IL)-8 in vivo regardless of the menstrual cycle phase and respond to oestradiol by up-regulating IL-1-induced IL-8 expression in vitro. Mol Hum Reprod: 2001; 7 9 859 866 (Pubitemid 32842754)
72. Bulun S. E., Monsavais D., Pavone M. E., et al. Role of estrogen receptor-β in endometriosis. Semin Reprod Med: 2012; 30 1 39 45
73. Gashaw I., Stiller S., Böing C., Kimmig R., Winterhager E. Premenstrual regulation of the pro-angiogenic factor CYR61 in human endometrium. Endocrinology: 2008; 149 5 2261 2269 (Pubitemid 351574533)
74. Zhao L., Wu H., Zhou X., Wang Q., Zhu W., Chen J. Effects of progressive muscular relaxation training on anxiety, depression and quality of life of endometriosis patients under gonadotrophin-releasing hormone agonist therapy. Eur J Obstet Gynecol Reprod Biol: 2012; 162 2 211 215
75. Absenger Y., Hess-Stumpp H., Kreft B., et al. Cyr61, a deregulated gene in endometriosis. Mol Hum Reprod: 2004; 10 6 399 407 (Pubitemid 38714372)
76. Gashaw I., Hastings J. M., Jackson K. S., Winterhager E., Fazleabas A. T. Induced endometriosis in the baboon (Papio anubis) increases the expression of the proangiogenic factor CYR61 (CCN1) in eutopic and ectopic endometria. Biol Reprod: 2006; 74 6 1060 1066 (Pubitemid 47394277)
77. Ishizuka M., Hatori M., Suzuki T., et al. Sex steroid receptors in rheumatoid arthritis. Clin Sci (Lond): 2004; 106 3 293 300 (Pubitemid 38365836)
78. Tabibzadeh S. S., Santhanam U., Sehgal P. B., May L. T. Cytokine-induced production of IFN-beta 2/IL-6 by freshly explanted human endometrial stromal cells. Modulation by estradiol-17 beta. J Immunol: 1989; 142 9 3134 3139 (Pubitemid 19129933)
79. Ray P., Ghosh S. K., Zhang D. H., Ray A. Repression of interleukin-6 gene expression by 17 beta-estradiol: inhibition of the DNA-binding activity of the transcription factors NF-IL6 and NF-kappa B by the estrogen receptor. FEBS Lett: 1997; 409 1 79 85 (Pubitemid 27248571)
80. Su E. J., Lin Z. H., Zeine R., et al. Estrogen receptor-beta mediates cyclooxygenase-2 expression and vascular prostanoid levels in human placental villous endothelial cells. Am J Obstet Gynecol: 2009; 200 4 e1 e8
81. Bulun S. E., Cheng Y. H., Pavone M. E., et al. Estrogen receptor-beta, estrogen receptor-alpha, and progesterone resistance in endometriosis. Semin Reprod Med: 2010; 28 1 36 43
82. Evans J., Salamonsen L. A. Inflammation, leukocytes and menstruation. Rev Endocr Metab Disord: 2012; 13 4 277 288
83. Hudelist G., Keckstein J., Czerwenka K., et al. Estrogen receptor beta and matrix metalloproteinase 1 are coexpressed in uterine endometrium and endometriotic lesions of patients with endometriosis. Fertil Steril: 2005; 84 02 1249 1256 (Pubitemid 41396552)
84. Sato T., Ito A., Mori Y., Yamashita K., Hayakawa T., Nagase H. Hormonal regulation of collagenolysis in uterine cervical fibroblasts. Modulation of synthesis of procollagenase, prostromelysin and tissue inhibitor of metalloproteinases (TIMP) by progesterone and oestradiol-17 beta. Biochem J: 1991; 275 Pt 3 645 650
85. Ryu K., Park C., Lee Y. Hypoxia-inducible factor 1 alpha represses the transcription of the estrogen receptor alpha gene in human breast cancer cells. Biochem Biophys Res Commun: 2011; 407 4 831 836
86. Wu M. H., Lu C. W., Chang F. M., Tsai S. J. Estrogen receptor expression affected by hypoxia inducible factor-1α in stromal cells from patients with endometriosis. Taiwan J Obstet Gynecol: 2012; 51 1 50 54
87. Polotsky V. Y., Rubin A. E., Balbir A., et al. Intermittent hypoxia causes REM sleep deficits and decreases EEG delta power in NREM sleep in the C57BL/6J mouse. Sleep Med: 2006; 7 1 7 16 (Pubitemid 43033539)
88. Chwalisz K., Garfield R. E. Role of nitric oxide in implantation and menstruation. Hum Reprod: 2000; 15 03 96 111
89. Thomas D. D., Ridnour L. A., Isenberg J. S., et al. The chemical biology of nitric oxide: implications in cellular signaling. Free Radic Biol Med: 2008; 45 1 18 31
90. Han G., Magee T., Khorram O. Regulation of nitric oxide synthase isoforms by estrogen in the human endometrium. Fertil Steril: 2005; 84 02 1220 1227 (Pubitemid 41396548)
91. Kakui K., Itoh H., Sagawa N., et al. Augmented endothelial nitric oxide synthase (eNOS) protein expression in human pregnant myometrium: possible involvement of eNOS promoter activation by estrogen via both estrogen receptor (ER)alpha and ERbeta. Mol Hum Reprod: 2004; 10 2 115 122 (Pubitemid 38196513)
92. Jang E. J., Seok Y. M., Arterburn J. B., Olatunji L. A., Kim I. K. GPER-1 agonist G1 induces vasorelaxation through activation of epidermal growth factor receptor-dependent signalling pathway. J Pharm Pharmacol: 2013; 65 10 1488 1499
93. Plante B. J., Lessey B. A., Taylor R. N., et al. G protein-coupled estrogen receptor (GPER) expression in normal and abnormal endometrium. Reprod Sci: 2012; 19 7 684 693
94. Nanni S., Benvenuti V., Grasselli A., et al. Endothelial NOS, estrogen receptor beta, and HIFs cooperate in the activation of a prognostic transcriptional pattern in aggressive human prostate cancer. J Clin Invest: 2009; 119 5 1093 1108
95. Prossnitz E. R., Barton M. The G-protein-coupled estrogen receptor GPER in health and disease. Nat Rev Endocrinol: 2011; 7 12 715 726
96. Yates M. A., Li Y., Chlebeck P. J., Offner H. GPR30, but not estrogen receptor-alpha, is crucial in the treatment of experimental autoimmune encephalomyelitis by oral ethinyl estradiol. BMC Immunol: 2010; 11 20
97. Brunsing R. L., Prossnitz E. R. Induction of interleukin-10 in the T helper type 17 effector population by the G protein coupled estrogen receptor (GPER) agonist G-1. Immunology: 2011; 134 1 93 106
98. Serhan C. N., Samuelsson B. Lipoxins: a new series of eicosanoids (biosynthesis, stereochemistry, and biological activities). Adv Exp Med Biol: 1988; 229 1 14
99. Hedqvist P., Raud J., Palmertz U., Haeggström J., Nicolaou K. C., Dahlén S. E. Lipoxin A4 inhibits leukotriene B4-induced inflammation in the hamster cheek pouch. Acta Physiol Scand: 1989; 137 4 571 572 (Pubitemid 20005054)
100. Lee T. H., Lympany P., Crea A. E., Spur B. W. Inhibition of leukotriene B4-induced neutrophil migration by lipoxin A4: structure-function relationships. Biochem Biophys Res Commun: 1991; 180 3 1416 1421
101. Badr K. F., DeBoer D. K., Schwartzberg M., Serhan C. N. Lipoxin A4 antagonizes cellular and in vivo actions of leukotriene D4 in rat glomerular mesangial cells: evidence for competition at a common receptor. Proc Natl Acad Sci U S A: 1989; 86 9 3438 3442 (Pubitemid 19129626)
102. McMahon B., Mitchell D., Shattock R., Martin F., Brady H. R., Godson C. Lipoxin, leukotriene, and PDGF receptors cross-talk to regulate mesangial cell proliferation. FASEB J: 2002; 16 13 1817 1819
103. Russell R., Gori I., Pellegrini C., Kumar R., Achtari C., Canny G. O. Lipoxin A4 is a novel estrogen receptor modulator. FASEB J: 2011; 25 12 4326 4337
104. Fiore S., Romano M., Reardon E. M., Serhan C. N. Induction of functional lipoxin A4 receptors in HL-60 cells. Blood: 1993; 81 12 3395 3403 (Pubitemid 23172926)
105. Fiore S., Maddox J. F., Perez H. D., Serhan C. N. Identification of a human cDNA encoding a functional high affinity lipoxin A4 receptor. J Exp Med: 1994; 180 1 253 260 (Pubitemid 24181074)
106. Serhan C. N. Controlling the resolution of acute inflammation: a new genus of dual anti-inflammatory and proresolving mediators. J Periodontol: 2008; 79 (8, Suppl): 1520 1526
107. Chiang N., Serhan C. N., Dahlén S. E., et al. The lipoxin receptor ALX: potent ligand-specific and stereoselective actions in vivo. Pharmacol Rev: 2006; 58 3 463 487 (Pubitemid 44394909)
108. Salamonsen L. A., Woolley D. E. Menstruation: induction by matrix metalloproteinases and inflammatory cells. J Reprod Immunol: 1999; 44 1-2 1 27 (Pubitemid 29457769)
109. Bulun S. E., Cheng Y. H., Pavone M. E., et al. Estrogen receptor-beta, estrogen receptor-alpha, and progesterone resistance in endometriosis. Semin Reprod Med: 2010; 28 1 36 43
110. McDonnell D. P., Norris J. D. Connections and regulation of the human estrogen receptor. Science: 2002; 296 5573 1642 1644 (Pubitemid 34579150)
111. Coleman K. M., Smith C. L. Intracellular signaling pathways: nongenomic actions of estrogens and ligand-independent activation of estrogen receptors. Front Biosci: 2001; 6 D1379 D1391
112. Weigel N. L., Zhang Y. Ligand-independent activation of steroid hormone receptors. J Mol Med (Berl): 1998; 76 7 469 479 (Pubitemid 28261256)
113. Hafner F., Holler E., von Angerer E. Effect of growth factors on estrogen receptor mediated gene expression. J Steroid Biochem Mol Biol: 1996; 58 4 385 393 (Pubitemid 26348972)
114. Gori I., Pellegrini C., Staedler D., Russell R., Jan C., Canny G. O. Tumor necrosis factor-. α activates estrogen signaling pathways in endometrial epithelial cells via estrogen receptor α Mol Cell Endocrinol: 2011; 345 1-2 27 37
115. Tabibzadeh S. Cytokines and the hypothalamic-pituitary-ovarian- endometrial axis. Hum Reprod: 1994; 9 5 947 967 (Pubitemid 24168083)
116. Baulieu E. E. RU486: a compound that gets itself talked about. Hum Reprod: 1994; 9 01 1 6
117. Kachkache M., Acker G. M., Chaouat G., Noun A., Garabédian M. Hormonal and local factors control the immunohistochemical distribution of immunocytes in the rat uterus before conceptus implantation: effects of ovariectomy, fallopian tube section, and injection. Biol Reprod: 1991; 45 6 860 868
118. Tibbetts T. A., Conneely O. M., O'Malley B. W. Progesterone via its receptor antagonizes the pro-inflammatory activity of estrogen in the mouse uterus. Biol Reprod: 1999; 60 5 1158 1165 (Pubitemid 29196768)
119. Hughes G. C. Progesterone and autoimmune disease. Autoimmun Rev: 2012; 11 6-7 A502 A514
120. Munoz-Suano A., Hamilton A. B., Betz A. G. Gimme shelter: the immune system during pregnancy. Immunol Rev: 2011; 241 1 20 38
121. Hazell G. G., Yao S. T., Roper J. A., Prossnitz E. R., O'Carroll A. M., Lolait S. J. Localisation of GPR30, a novel G protein-coupled oestrogen receptor, suggests multiple functions in rodent brain and peripheral tissues. J Endocrinol: 2009; 202 2 223 236
122. Tseng L., Gurpide E. Induction of human endometrial estradiol dehydrogenase by progestins. Endocrinology: 1975; 97 4 825 833
123. Tseng L., Gurpide E. Effects of progestins on estradiol receptor levels in human endometrium. J Clin Endocrinol Metab: 1975; 41 2 402 404
124. Burney R. O., Talbi S., Hamilton A. E., et al. Gene expression analysis of endometrium reveals progesterone resistance and candidate susceptibility genes in women with endometriosis. Endocrinology: 2007; 148 8 3814 3826 (Pubitemid 47105847)
125. Burney R. O., Hamilton A. E., Aghajanova L., et al. MicroRNA expression profiling of eutopic secretory endometrium in women with versus without endometriosis. Mol Hum Reprod: 2009; 15 10 625 631
126. Kurita T., Lee K. J., Cooke P. S., Lydon J. P., Cunha G. R. Paracrine regulation of epithelial progesterone receptor and lactoferrin by progesterone in the mouse uterus. Biol Reprod: 2000; 62 4 831 838 (Pubitemid 30173794)
127. Large M. J., DeMayo F. J. The regulation of embryo implantation and endometrial decidualization by progesterone receptor signaling. Mol Cell Endocrinol: 2012; 358 2 155 165
128. Tan H., Yi L., Rote N. S., Hurd W. W., Mesiano S. Progesterone receptor-A and -B have opposite effects on proinflammatory gene expression in human myometrial cells: implications for progesterone actions in human pregnancy and parturition. J Clin Endocrinol Metab: 2012; 97 5 E719 E730
129. Attia G. R., Zeitoun K., Edwards D., Johns A., Carr B. R., Bulun S. E. Progesterone receptor isoform A but not B is expressed in endometriosis. J Clin Endocrinol Metab: 2000; 85 8 2897 2902 (Pubitemid 32269170)
130. Bukulmez O., Hardy D. B., Carr B. R., Word R. A., Mendelson C. R. Inflammatory status influences aromatase and steroid receptor expression in endometriosis. Endocrinology: 2008; 149 3 1190 1204 (Pubitemid 351397966)
131. Igarashi T. M., Bruner-Tran K. L., Yeaman G. R., et al. Reduced expression of progesterone receptor-B in the endometrium of women with endometriosis and in cocultures of endometrial cells exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Fertil Steril: 2005; 84 1 67 74 (Pubitemid 40991462)
132. Khoufache K., Michaud N., Harir N., Kibangou Bondza P., Akoum A. Anomalies in the inflammatory response in endometriosis and possible consequences: a review. Minerva Endocrinol: 2012; 37 1 75 92
133. Attar E., Tokunaga H., Imir G., et al. Prostaglandin E2 via steroidogenic factor-1 coordinately regulates transcription of steroidogenic genes necessary for estrogen synthesis in endometriosis. J Clin Endocrinol Metab: 2009; 94 2 623 631
134. Jabbour H. N., Kelly R. W., Fraser H. M., Critchley H. O. Endocrine regulation of menstruation. Endocr Rev: 2006; 27 1 17 46 (Pubitemid 43228237)
135. Lessey B. A., Young S. L. The structure, function, and evaluation of the female reproductive tract. In: Strauss J. F. III, Barbieri R. L., eds. Reproductive Endocrinology: Physiology, Pathophysiology, and Clinical Management. Philadelphia, PA Saunders Elsevier: 2012; 192 235
136. Tabibzadeh S. The signals and molecular pathways involved in human menstruation, a unique process of tissue destruction and remodelling. Mol Hum Reprod: 1996; 2 2 77 92 (Pubitemid 126715854)
137. Markee J. E. Menstruation in intraocular endometrial transplants in the Rhesus monkey. Am J Obstet Gynecol: 1978; 131 5 558 559 (Pubitemid 8355434)
138. Curry T. E. Jr, Osteen K. G. The matrix metalloproteinase system: changes, regulation, and impact throughout the ovarian and uterine reproductive cycle. Endocr Rev: 2003; 24 4 428 465 (Pubitemid 37056240)
139. Maybin J. A., Critchley H. O. Progesterone: a pivotal hormone at menstruation. Ann N Y Acad Sci: 2011; 1221 88 97
140. Henriet P., Gaide Chevronnay H. P., Marbaix E. The endocrine and paracrine control of menstruation. Mol Cell Endocrinol: 2012; 358 2 197 207
141. Guo Y., He B., Xu X., Wang J. Comprehensive analysis of leukocytes, vascularization and matrix metalloproteinases in human menstrual xenograft model. PLoS ONE: 2011; 6 2 e16840
142. Slayden O. D., Brenner R. M. A critical period of progesterone withdrawal precedes menstruation in macaques. Reprod Biol Endocrinol: 2006; 4 01 S6
143. Brenner R. M., Nayak N. R., Slayden O. D., Critchley H. O., Kelly R. W. Premenstrual and menstrual changes in the macaque and human endometrium: relevance to endometriosis. Ann N Y Acad Sci: 2002; 955 60 74, discussion 86-88, 396-406 (Pubitemid 34271063)
144. Nayak N. R., Critchley H. O., Slayden O. D., et al. Progesterone withdrawal up-regulates vascular endothelial growth factor receptor type 2 in the superficial zone stroma of the human and macaque endometrium: potential relevance to menstruation. J Clin Endocrinol Metab: 2000; 85 9 3442 3452
145. Pickles V. R. A plain-muscle stimulant in the menstruum. Nature: 1957; 180 4596 1198 1199
146. Downie J., Poyser N. L., Wunderlich M. Levels of prostaglandins in human endometrium during the normal menstrual cycle. J Physiol: 1974; 236 2 465 472
147. Baird D. T., Cameron S. T., Critchley H. O., et al. Prostaglandins and menstruation. Eur J Obstet Gynecol Reprod Biol: 1996; 70 1 15 17 (Pubitemid 27041933)
148. Wu M. H., Shoji Y., Chuang P. C., Tsai S. J. Endometriosis: disease pathophysiology and the role of prostaglandins. Expert Rev Mol Med: 2007; 9 2 1 20 (Pubitemid 46151877)
149. Lee J., Banu S. K., Burghardt R. C., Starzinski-Powitz A., Arosh J. A. Selective inhibition of prostaglandin E2 receptors EP2 and EP4 inhibits adhesion of human endometriotic epithelial and stromal cells through suppression of integrin-mediated mechanisms. Biol Reprod: 2013; 88 3 77
150. Lousse J. C., Van Langendonckt A., Defrere S., Ramos R. G., Colette S., Donnez J. Peritoneal endometriosis is an inflammatory disease. Front Biosci (Elite Ed): 2012; 4 23 40
151. Kyama C. M., Overbergh L., Debrock S., et al. Increased peritoneal and endometrial gene expression of biologically relevant cytokines and growth factors during the menstrual phase in women with endometriosis. Fertil Steril: 2006; 85 6 1667 1675 (Pubitemid 43816424)
152. Maybin J. A., Hirani N., Jabbour H. N., Critchley H. O. Novel roles for hypoxia and prostaglandin E2 in the regulation of IL-8 during endometrial repair. Am J Pathol: 2011; 178 3 1245 1256
153. D'Hooghe T. M., Bambra C. S., Xiao L., Peixe K., Hill J. A. Effect of menstruation and intrapelvic injection of endometrium on inflammatory parameters of peritoneal fluid in the baboon (Papio anubis and Papio cynocephalus). Am J Obstet Gynecol: 2001; 184 5 917 925 (Pubitemid 32368110)
154. Dmowski W. P., Gebel H. M., Braun D. P. The role of cell-mediated immunity in pathogenesis of endometriosis. Acta Obstet Gynecol Scand Suppl: 1994; 159 7 14 (Pubitemid 24174510)
155. Seli E., Arici A. Endometriosis: interaction of immune and endocrine systems. Semin Reprod Med: 2003; 21 2 135 144 (Pubitemid 36875689)
156. Lydon J. P., DeMayo F. J., Funk C. R., et al. Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities. Genes Dev: 1995; 9 18 2266 2278
157. Otsuki Y. Apoptosis in human endometrium: apoptotic detection methods and signaling. Med Electron Microsc: 2001; 34 3 166 173
158. Kokawa K., Shikone T., Nakano R. Apoptosis in the human uterine endometrium during the menstrual cycle. J Clin Endocrinol Metab: 1996; 81 11 4144 4147 (Pubitemid 26380430)
159. Konno R., Yamakawa H., Utsunomiya H., Ito K., Sato S., Yajima A. Expression of survivin and Bcl-2 in the normal human endometrium. Mol Hum Reprod: 2000; 6 6 529 534 (Pubitemid 30365798)
160. Lovely L. P., Fazleabas A. T., Fritz M. A., McAdams D. G., Lessey B. A. Prevention of endometrial apoptosis: randomized prospective comparison of human chorionic gonadotropin versus progesterone treatment in the luteal phase. J Clin Endocrinol Metab: 2005; 90 4 2351 2356 (Pubitemid 40586284)
161. King A. Uterine leukocytes and decidualization. Hum Reprod Update: 2000; 6 1 28 36 (Pubitemid 30099340)
162. Marbaix E., Kokorine I., Moulin P., Donnez J., Eeckhout Y., Courtoy P. J. Menstrual breakdown of human endometrium can be mimicked in vitro and is selectively and reversibly blocked by inhibitors of matrix metalloproteinases. Proc Natl Acad Sci U S A: 1996; 93 17 9120 9125 (Pubitemid 26282028)
163. Rodgers W. H., Matrisian L. M., Giudice L. C., et al. Patterns of matrix metalloproteinase expression in cycling endometrium imply differential functions and regulation by steroid hormones. J Clin Invest: 1994; 94 3 946 953 (Pubitemid 24286434)
164. Irwin J. C., Kirk D., Gwatkin R. BL, Navre M., Cannon P., Giudice L. C. Human endometrial matrix metalloproteinase-2, a putative menstrual proteinase. Hormonal regulation in cultured stromal cells and messenger RNA expression during the menstrual cycle. J Clin Invest: 1996; 97 2 438 447
165. Henriet P., Cornet P. B., Lemoine P., et al. Circulating ovarian steroids and endometrial matrix metalloproteinases (MMPs). Ann N Y Acad Sci: 2002; 955 119 138, discussion 157-158, 396-406 (Pubitemid 34271070)
166. Wentz A. C. Premenstrual spotting: its association with endometriosis but not luteal phase inadequacy. Fertil Steril: 1980; 33 6 605 607 (Pubitemid 10059225)
167. Tabibzadeh S., Mason J. M., Shea W., Cai Y., Murray M. J., Lessey B. Dysregulated expression of ebaf, a novel molecular defect in the endometria of patients with infertility. J Clin Endocrinol Metab: 2000; 85 7 2526 2536 (Pubitemid 32269211)
168. Bartosik D., Damjanov I., Viscarello R. R., Riley J. A. Immunoproteins in the endometrium: clinical correlates of the presence of complement fractions C3 and C4. Am J Obstet Gynecol: 1987; 156 1 11 15 (Pubitemid 17001080)
169. Isaacson K. B., Coutifaris C., Garcia C. R., Lyttle C. R. Production and secretion of complement component 3 by endometriotic tissue. J Clin Endocrinol Metab: 1989; 69 5 1003 1009 (Pubitemid 19261830)
170. Sundstrom S. A., Komm B. S., Ponce-de-Leon H., Yi Z., Teuscher C., Lyttle C. R. Estrogen regulation of tissue-specific expression of complement C3. J Biol Chem: 1989; 264 28 16941 16947 (Pubitemid 19243599)
171. Hasty L. A., Lambris J. D., Lessey B. A., Pruksananonda K., Lyttle C. R. Hormonal regulation of complement components and receptors throughout the menstrual cycle. Am J Obstet Gynecol: 1994; 170 1, Pt 1 168 175 (Pubitemid 24084051)
172. Young S. L., Lessey B. A., Fritz M. A., et al. In vivo and in vitro evidence suggest that HB-EGF regulates endometrial expression of human decay-accelerating factor. J Clin Endocrinol Metab: 2002; 87 3 1368 1375 (Pubitemid 36121110)
173. Palomino W. A., Argandoña F., Azúa R., Kohen P., Devoto L. Complement C3 and decay-accelerating factor expression levels are modulated by human chorionic gonadotropin in endometrial compartments during the implantation window. Reprod Sci: 2013; 20 9 1103 1110
174. Lessey B. A. Two pathways of progesterone action in the human endometrium: implications for implantation and contraception. Steroids: 2003; 68 10-13 809 815 (Pubitemid 37532404)
175. Lessey B. A., Gui Y., Apparao K. B., Young S. L., Mulholland J. Regulated expression of heparin-binding EGF-like growth factor (HB-EGF) in the human endometrium: a potential paracrine role during implantation. Mol Reprod Dev: 2002; 62 4 446 455 (Pubitemid 34743056)
176. Illera M. J., Rumen J., Yuan L. W., Lessey B. A. Peritoneal fluid from infertile women with endometriosis and aberrant endometrial integrin expression blocks embryo implantation in a mouse model. The Endocrine Society 77th Annual Meeting; 1995;P2-98:315
177. Kim J. J., Taylor H. S., Lu Z., et al. Altered expression of HOXA10 in endometriosis: potential role in decidualization. Mol Hum Reprod: 2007; 13 5 323 332 (Pubitemid 47061643)
178. Taylor H. S., Bagot C., Kardana A., Olive D., Arici A. HOX gene expression is altered in the endometrium of women with endometriosis. Hum Reprod: 1999; 14 5 1328 1331 (Pubitemid 29224916)
179. Lessey B. A., Castelbaum A. J., Sawin S. W., et al. Aberrant integrin expression in the endometrium of women with endometriosis. J Clin Endocrinol Metab: 1994; 79 2 643 649 (Pubitemid 24256567)
180. Kaul A., Nagamani M., Nowicki B. Decreased expression of endometrial decay accelerating factor (DAF), a complement regulatory protein, in patients with luteal phase defect. Am J Reprod Immunol: 1995; 34 4 236 240
181. Banadakoppa M., Goluszko P., Liebenthal D., Yallampalli C. Nitric oxide induces segregation of decay accelerating factor (DAF or CD55) from the membrane lipid-rafts and its internalization in human endometrial cells. Cell Biol Int: 2012; 36 10 901 907
182. Khorram O., Lessey B. A. Alterations in expression of endometrial endothelial nitric oxide synthase and alpha(v)beta(3) integrin in women with endometriosis. Fertil Steril: 2002; 78 4 860 864
183. Aisemberg J., Vercelli C. A., Bariani M. V., Billi S. C., Wolfson M. L., Franchi A. M. Progesterone is essential for protecting against LPS-induced pregnancy loss. LIF as a potential mediator of the anti-inflammatory effect of progesterone. PLoS ONE: 2013; 8 2 e56161
184. Ota H., Igarashi S., Hatazawa J., Tanaka T. Endothelial nitric oxide synthase in the endometrium during the menstrual cycle in patients with endometriosis and adenomyosis. Fertil Steril: 1998; 69 2 303 308 (Pubitemid 28117111)
185. Cullinan E. B., Abbondanzo S. J., Anderson P. S., Pollard J. W., Lessey B. A., Stewart C. L. Leukemia inhibitory factor (LIF) and LIF receptor expression in human endometrium suggests a potential autocrine/paracrine function in regulating embryo implantation. Proc Natl Acad Sci U S A: 1996; 93 7 3115 3120 (Pubitemid 26114373)
186. Espey L. L. Ovulation as an inflammatory reaction-a hypothesis. Biol Reprod: 1980; 22 1 73 106
187. Finn C. A. Implantation, menstruation and inflammation. Biol Rev Camb Philos Soc: 1986; 61 4 313 328
188. Borrelli G. M., Abrao M. S., Mechsner S. Can chemokines be used as biomarkers for endometriosis? A systematic review. Hum Reprod: 2014; 29 2 253 266
189. May K. E., Conduit-Hulbert S. A., Villar J., Kirtley S., Kennedy S. H., Becker C. M. Peripheral biomarkers of endometriosis: a systematic review. Hum Reprod Update: 2010; 16 6 651 674
190. Kyama C. M., Mihalyi A., Simsa P., et al. Role of cytokines in the endometrial-peritoneal cross-talk and development of endometriosis. Front Biosci (Elite Ed): 2009; 1 444 454 (Elite Ed)
191. Bulun S. E. Endometriosis. N Engl J Med: 2009; 360 3 268 279